INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Why Early RTSM Involvement Matters

  Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.

• Bringing Intelligence Into The Flow Of Clinical Trials

  AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.

• How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

  Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

• IRT vs. RTSM: What Sponsors Need To Know When Choosing Clinical Trial Technology

  5/6/2026

  Mastering the nuances between IRT and RTSM allows trial teams to move past confusing jargon and focus on the supply intelligence and randomization logic essential for study integrity.

• Key Trends Driving Digital Transformation In Clinical Research

  12/10/2025

  AI, sensors, and evolving regulations are redefining digital health—driving data insights, sensor-based endpoints, and regulatory pathways that shape the future of clinical research.

   

• Navigating The Evolving Regulatory And Data Landscape

  8/19/2024

  Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.

• What Is Healthcare Data Interoperability And Why Does It Matter For Clinical Research?

  1/28/2025

  Explore how healthcare data interoperability can transform patient outcomes, streamline clinical research, and enhance efficiencies while addressing key challenges and global initiatives.

• DTx Company Leverages Real-World Evidence Platform In Registry Study

  8/19/2024

  Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.